Bone Health Awareness Sale ends in 00days 00hrs 00min
← Learn

Ozempic, Wegovy, and Muscle Loss After Menopause: What the Research Actually Shows

July 27, 2026 · Optimum Research Team

A GLP-1 medication does what it is designed to do. Appetite drops, and the weight comes off, often faster and further than years of previous attempts managed. That result is not in question here.

What gets far less attention in the conversation around these drugs is what else leaves the body along with the fat. Body composition substudies built into the major GLP-1 trials measure this directly with DXA scanning, which separates fat mass from lean mass rather than just tracking pounds on a scale. Across several of these substudies, a real share of total weight lost is lean tissue rather than fat, and muscle makes up most of that lean-tissue category.

What the trial data actually measured

In the STEP 1 trial's DXA substudy, people taking semaglutide lost 9.7 percent of their total lean body mass over the course of the study. In the SURMOUNT-1 DXA substudy of tirzepatide, roughly 26 percent of total weight lost, about 5.6 kilograms, was lean tissue. A 2025 review pulling together data across multiple GLP-1 trials put the range at roughly 25 to 40 percent of total weight lost coming from lean tissue.

These are trial measurements, not a claim that applies identically to every person on these medications. Diet quality, activity level, dose, and duration all move the number. But the direction is consistent across every substudy that has looked, and it applies to women in their 50s and 60s exactly as it applies to trial participants overall.

Why the standard protein plan runs into a real wall

The advice given to protect muscle on a GLP-1 medication is almost always the same. Eat more protein, generally somewhere around 1.6 grams per kilogram of body weight per day, and lift weights several times a week.

That advice is not wrong. Protein supplies the raw material muscle needs to rebuild, and resistance training gives the body a reason to use it. The problem is a practical one that shows up constantly in the accounts of women taking these medications. The same appetite suppression that makes the drug effective for weight loss also makes hitting a high daily protein target genuinely difficult. A 6-ounce chicken breast can feel like more food than an appetite that has been chemically dialed down can manage, and pushing through that discomfort meal after meal is not sustainable for most people.

There is a second, less visible problem underneath the first one. Even among people who do manage to hit their protein targets and keep up a consistent lifting schedule, muscle loss on these medications still shows up. Protein is the material. The signal that tells the body to put that material to use rebuilding muscle tissue is a separate biological system, and it is the part that a protein target and a set of squats do not address.

What an 8-week trial found when researchers looked inside muscle tissue

Here is exactly what that research measured, and where it stops short.

In an 8-week human trial, 16 healthy adults took 500 milligrams of shilajit daily, and researchers took biopsies of muscle tissue to measure gene activity directly, rather than relying on a strength test or a scale. The results, read through RT-PCR analysis, showed a cluster of 17 genes tied to muscle repair and the extracellular matrix, the collagen scaffold that holds muscle fibers together, switched on. The collagen genes in that cluster rose substantially over baseline, with the 3 largest increases at roughly 5.2, 5.1, and 4.6 times higher than before supplementation (https://pubmed.ncbi.nlm.nih.gov/27414521/). This is a gene-expression finding in a small mixed group, not a study that measured muscle mass gained on a tape measure, and it should be read as exactly that. What it shows is that shilajit switched on the muscle's own rebuilding machinery at the cellular level, distinct from simply supplying more raw material for that machinery to use.

A separate 8-week randomized controlled trial in 63 active men tested shilajit against a placebo under a fatigue protocol. The men taking 500 milligrams daily retained significantly more of their maximal strength after repeated fatigue than the placebo group did, and a marker of connective tissue breakdown, hydroxyproline, was lower in the shilajit group (https://pubmed.ncbi.nlm.nih.gov/30728074/). This trial was conducted in men, and that limitation should be stated plainly rather than glossed over. It does not establish that the same effect occurs at the same magnitude in postmenopausal women. What it adds to the muscle-biopsy finding is a second, independent measurement pointing at the same rebuilding signal, this time showing up as strength retained rather than strength lost.

Read together, these are 2 real, controlled human trials, not marketing claims, and neither one says shilajit builds muscle mass by itself. What they show is a rebuilding signal switched on at the cellular level and strength held onto under stress, which is a different mechanism than the raw-material approach that protein and creatine take.

For the woman worried about estrogen and cancer risk

Any conversation involving cellular signaling in the body eventually runs into a reasonable question about hormones, especially for a woman with breast cancer in her family history. Shilajit is not a hormone and does not add estrogen to the body. Laboratory research has tested shilajit directly against MCF-7 and MDA-MB-231 cells, the most studied estrogen-receptor-positive breast cancer cell lines used in research, and found that it reduced the viability of those cancer cells and triggered programmed cell death, while normal breast cells in the same experiments were left unharmed (https://pubmed.ncbi.nlm.nih.gov/34466597/). That is laboratory, cell-line research, not a human cancer trial, and it should be read as exactly that. It is also the reason this compound does not carry the same hesitation a synthetic hormone conversation usually does.

Safety and the purity question

Across every human clinical study conducted on shilajit, zero serious adverse events have been reported. It is not a stimulant, and it does not act on appetite or blood sugar, which is why it works on a separate system from a GLP-1 medication rather than interfering with it.

Purity is a fair thing to ask about any mineral resin. Optimum shilajit comes from the Altai mountains, cold pressed and purified, and every batch is third-party lab tested for both heavy metals and mycotoxins, with results posted. Optimum is a small, family owned company out of Florida, and a real person answers when a customer reaches out. It ships as a box of tablets, not a loose raw powder that loses potency before it reaches the person taking it.

What this actually means for you

If a GLP-1 medication is working for you, nothing in this research is a reason to reconsider it. The weight loss is real and it matters. What the research points to is a gap in the plan built around the medication, a plan that hands most women a protein target and a workout schedule and calls the muscle question answered, while the appetite suppression that makes the drug work also makes that protein target genuinely hard to hit, and while the rebuilding signal underneath it all rarely gets mentioned at all.

Keeping the medication and adding attention to that signal are not opposite choices. They are the same plan, with the missing layer added back in.

Common questions

Does Ozempic or Wegovy actually cause muscle loss?
Weight loss on Ozempic and Wegovy comes with some muscle loss. Body composition substudies of the major GLP-1 trials find that a real share of weight lost is lean tissue, which includes muscle, and a 2025 review of multiple trials put the range at roughly 25 to 40%. It is a trial finding, not a promise for every person.
Can I just eat more protein to stop the muscle loss?
Eating more protein helps, but it does not solve the problem on its own. The appetite suppression that makes GLP-1 drugs work also makes a target of about 1.6 grams per kilogram of body weight hard to reach, and the signal that tells the body to rebuild muscle is a separate system that protein does not supply.
What does the research on shilajit show for muscle specifically?
The research on shilajit and muscle includes 2 human trials that point to a rebuilding signal. In 16 healthy adults, 2 months of shilajit switched on 17 muscle repair and collagen genes in biopsies. In 63 active men, shilajit helped them hold onto strength under repeated fatigue. Neither trial shows it builds muscle mass on its own.
Should I stop my GLP-1 medication because of this?

No. Nothing in this research is a reason to give up a medication that is working. The research points to a gap in the plan around the drug, specifically that most of the advice available protects muscle through diet and training alone, while the signaling side of muscle rebuilding gets left out entirely. Keeping the medication and adding attention to that signal are not in conflict.

Is shilajit safe to take alongside a GLP-1 medication?

Shilajit acts on a different system than a GLP-1 drug does. The medication works on appetite and blood sugar. Shilajit and its fulvic acid work on cellular signaling tied to tissue repair. Across every human clinical study conducted on shilajit, zero serious adverse events have been reported. Spacing doses by a couple of hours from other medications is a reasonable general practice, and any specific concern is worth raising with whoever manages your care.

Optimum Shilajit box

Optimum Shilajit

If you want to give your muscle the signal the research points to, you can find Optimum Shilajit.

See Optimum Shilajit